STAAR Surgical Net Income
| STAA Stock | USD 18.15 0.11 0.61% |
As of the 5th of February, STAAR Surgical owns the standard deviation of 3.11, and Risk Adjusted Performance of (0.12). In relation to fundamental indicators, the technical analysis model makes it possible for you to check practical technical drivers of STAAR Surgical, as well as the relationship between them.
STAAR Surgical Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 3.2198 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -23.2 M | -22.1 M | |
| Net Loss | -23.2 M | -22.1 M | |
| Net Income Applicable To Common Shares | 44.6 M | 46.8 M | |
| Net Income Per Share | 0.52 | 0.55 | |
| Net Income Per E B T | 1.01 | 1.17 |
STAAR | Net Income | Build AI portfolio with STAAR Stock |
Analyzing STAAR Surgical's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing STAAR Surgical's current valuation and future prospects.
Latest STAAR Surgical's Net Income Growth Pattern
Below is the plot of the Net Income of STAAR Surgical over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in STAAR Surgical financial statement analysis. It represents the amount of money remaining after all of STAAR Surgical operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is STAAR Surgical's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in STAAR Surgical's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (20.21 M) | 10 Years Trend |
|
Net Income |
| Timeline |
STAAR Net Income Regression Statistics
| Arithmetic Mean | 877,504 | |
| Coefficient Of Variation | 1,964 | |
| Mean Deviation | 12,783,232 | |
| Median | (1,763,000) | |
| Standard Deviation | 17,229,894 | |
| Sample Variance | 296.9T | |
| Range | 62.9M | |
| R-Value | 0.02 | |
| Mean Square Error | 316.6T | |
| R-Squared | 0.0003 | |
| Significance | 0.95 | |
| Slope | 54,847 | |
| Total Sum of Squares | 4749.9T |
STAAR Net Income History
Other Fundumenentals of STAAR Surgical
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
STAAR Surgical Net Income component correlations
STAAR Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for STAAR Surgical is extremely important. It helps to project a fair market value of STAAR Stock properly, considering its historical fundamentals such as Net Income. Since STAAR Surgical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of STAAR Surgical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of STAAR Surgical's interrelated accounts and indicators.
Click cells to compare fundamentals
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STAAR Surgical. If investors know STAAR will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive STAAR Surgical assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth (0.10) | Earnings Share (1.96) | Revenue Per Share | Quarterly Revenue Growth 0.069 | Return On Assets |
The market value of STAAR Surgical is measured differently than its book value, which is the value of STAAR that is recorded on the company's balance sheet. Investors also form their own opinion of STAAR Surgical's value that differs from its market value or its book value, called intrinsic value, which is STAAR Surgical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STAAR Surgical's market value can be influenced by many factors that don't directly affect STAAR Surgical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STAAR Surgical's value and its price as these two are different measures arrived at by different means. Investors typically determine if STAAR Surgical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, STAAR Surgical's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
STAAR Surgical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to STAAR Surgical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of STAAR Surgical.
| 11/07/2025 |
| 02/05/2026 |
If you would invest 0.00 in STAAR Surgical on November 7, 2025 and sell it all today you would earn a total of 0.00 from holding STAAR Surgical or generate 0.0% return on investment in STAAR Surgical over 90 days. STAAR Surgical is related to or competes with Kestra Medical, Pulse Biosciences, Novocure, Azenta, Beta Bionics, BioLife Solutions, and Terns Pharmaceuticals. STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable ... More
STAAR Surgical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure STAAR Surgical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess STAAR Surgical upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.19) | |||
| Maximum Drawdown | 15.08 | |||
| Value At Risk | (5.66) | |||
| Potential Upside | 4.66 |
STAAR Surgical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for STAAR Surgical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as STAAR Surgical's standard deviation. In reality, there are many statistical measures that can use STAAR Surgical historical prices to predict the future STAAR Surgical's volatility.| Risk Adjusted Performance | (0.12) | |||
| Jensen Alpha | (0.58) | |||
| Total Risk Alpha | (0.77) | |||
| Treynor Ratio | (0.77) |
STAAR Surgical February 5, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.12) | |||
| Market Risk Adjusted Performance | (0.76) | |||
| Mean Deviation | 2.33 | |||
| Coefficient Of Variation | (587.14) | |||
| Standard Deviation | 3.11 | |||
| Variance | 9.65 | |||
| Information Ratio | (0.19) | |||
| Jensen Alpha | (0.58) | |||
| Total Risk Alpha | (0.77) | |||
| Treynor Ratio | (0.77) | |||
| Maximum Drawdown | 15.08 | |||
| Value At Risk | (5.66) | |||
| Potential Upside | 4.66 | |||
| Skewness | 0.0113 | |||
| Kurtosis | 0.2306 |
STAAR Surgical Backtested Returns
STAAR Surgical retains Efficiency (Sharpe Ratio) of -0.19, which indicates the firm had a -0.19 % return per unit of risk over the last 3 months. STAAR Surgical exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate STAAR Surgical's risk adjusted performance of (0.12), and Standard Deviation of 3.11 to confirm the risk estimate we provide. The entity owns a Beta (Systematic Risk) of 0.7, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, STAAR Surgical's returns are expected to increase less than the market. However, during the bear market, the loss of holding STAAR Surgical is expected to be smaller as well. At this point, STAAR Surgical has a negative expected return of -0.58%. Please make sure to validate STAAR Surgical's skewness, day typical price, and the relationship between the maximum drawdown and daily balance of power , to decide if STAAR Surgical performance from the past will be repeated at future time.
Auto-correlation | 0.72 |
Good predictability
STAAR Surgical has good predictability. Overlapping area represents the amount of predictability between STAAR Surgical time series from 7th of November 2025 to 22nd of December 2025 and 22nd of December 2025 to 5th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of STAAR Surgical price movement. The serial correlation of 0.72 indicates that around 72.0% of current STAAR Surgical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.72 | |
| Spearman Rank Test | 0.7 | |
| Residual Average | 0.0 | |
| Price Variance | 3.89 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
STAAR Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, STAAR Surgical reported net income of (20.21 Million). This is 105.92% lower than that of the Health Care Equipment & Supplies sector and 120.28% lower than that of the Health Care industry. The net income for all United States stocks is 103.54% higher than that of the company.
STAAR Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses STAAR Surgical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of STAAR Surgical could also be used in its relative valuation, which is a method of valuing STAAR Surgical by comparing valuation metrics of similar companies.STAAR Surgical is currently under evaluation in net income category among its peers.
STAAR Surgical ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, STAAR Surgical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to STAAR Surgical's managers, analysts, and investors.Environmental | Governance | Social |
STAAR Surgical Institutional Holders
Institutional Holdings refers to the ownership stake in STAAR Surgical that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of STAAR Surgical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing STAAR Surgical's value.| Shares | Palo Alto Investors, Llc | 2025-06-30 | 791.9 K | Dimensional Fund Advisors, Inc. | 2025-06-30 | 785.6 K | American Capital Management Inc | 2025-06-30 | 784.9 K | Defender Capital, Llc. | 2025-06-30 | 695.8 K | Citadel Advisors Llc | 2025-06-30 | 555.1 K | Jupiter Asset Management Limited | 2025-06-30 | 539.1 K | Northern Trust Corp | 2025-06-30 | 512.7 K | Charles Schwab Investment Management Inc | 2025-06-30 | 474.3 K | Two Sigma Investments Llc | 2025-06-30 | 407.4 K | Broadwood Capital Inc | 2025-06-30 | 13.5 M | Blackrock Inc | 2025-06-30 | 7.4 M |
STAAR Fundamentals
| Return On Equity | -0.25 | ||||
| Return On Asset | -0.0788 | ||||
| Profit Margin | (0.42) % | ||||
| Operating Margin | 0.26 % | ||||
| Current Valuation | 737.02 M | ||||
| Shares Outstanding | 49.37 M | ||||
| Shares Owned By Insiders | 0.49 % | ||||
| Shares Owned By Institutions | 99.51 % | ||||
| Number Of Shares Shorted | 4.03 M | ||||
| Price To Earning | 460.83 X | ||||
| Price To Book | 2.53 X | ||||
| Price To Sales | 3.89 X | ||||
| Revenue | 313.9 M | ||||
| Gross Profit | 170.33 M | ||||
| EBITDA | (5.72 M) | ||||
| Net Income | (20.21 M) | ||||
| Cash And Equivalents | 202.49 M | ||||
| Cash Per Share | 4.22 X | ||||
| Total Debt | 38.74 M | ||||
| Debt To Equity | 0.10 % | ||||
| Current Ratio | 6.37 X | ||||
| Book Value Per Share | 7.17 X | ||||
| Cash Flow From Operations | 15.72 M | ||||
| Short Ratio | 2.42 X | ||||
| Earnings Per Share | (1.96) X | ||||
| Price To Earnings To Growth | (4.89) X | ||||
| Target Price | 23.63 | ||||
| Number Of Employees | 1.16 K | ||||
| Beta | 1.07 | ||||
| Market Capitalization | 895.99 M | ||||
| Total Asset | 509.52 M | ||||
| Retained Earnings | (67.58 M) | ||||
| Working Capital | 297.63 M | ||||
| Current Asset | 49.07 M | ||||
| Current Liabilities | 17.89 M | ||||
| Net Asset | 509.52 M |
About STAAR Surgical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze STAAR Surgical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of STAAR Surgical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of STAAR Surgical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether STAAR Surgical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of STAAR Surgical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Staar Surgical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Staar Surgical Stock:Check out For information on how to trade STAAR Stock refer to our How to Trade STAAR Stock guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STAAR Surgical. If investors know STAAR will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive STAAR Surgical assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth (0.10) | Earnings Share (1.96) | Revenue Per Share | Quarterly Revenue Growth 0.069 | Return On Assets |
The market value of STAAR Surgical is measured differently than its book value, which is the value of STAAR that is recorded on the company's balance sheet. Investors also form their own opinion of STAAR Surgical's value that differs from its market value or its book value, called intrinsic value, which is STAAR Surgical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STAAR Surgical's market value can be influenced by many factors that don't directly affect STAAR Surgical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STAAR Surgical's value and its price as these two are different measures arrived at by different means. Investors typically determine if STAAR Surgical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, STAAR Surgical's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.